Novartis AG (NVS) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-03 (expected, time not announced). EPS estimate 1.89, revenue estimate 12.32B.
Over the last 12 reports the stock moved 2.5% on average (either way), rising 6 times and falling 6. EPS beat estimates 9 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-27 | 2.03 | 1.87 | +8.6% | 11.99B | 12.16B | +1.4% |
| Q2 FY2026 | 2026-07-21 | 1.96 | 1.77 | +10.7% | 11.74B | 11.38B | +1.8% |
| Q1 FY2026 | 2026-04-28 | 1.55 | 1.64 | -5.5% | 10.24B | 10.76B | -0.6% |
| Q4 FY2025 | 2026-02-04 | 1.57 | 1.54 | +1.9% | 10.57B | 10.88B | +2.1% |
| Q3 FY2025 | 2025-10-27 | 1.81 | 1.83 | -1.1% | 11.42B | 11.17B | -5.0% |
| Q2 FY2025 | 2025-07-16 | 1.94 | 1.88 | +3.2% | 11.79B | 11.27B | -2.8% |
| Q1 FY2025 | 2025-04-29 | 1.88 | 1.74 | +8.0% | 12.00B | 10.77B | +0.4% |
| Q4 FY2024 | 2025-01-31 | 1.81 | 1.65 | +9.7% | 12.31B | 11.75B | +2.4% |